Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies on 2-(3-benzoylphenyl) propionic acid (Orudis). A double-blind cross-over trial in patients with rheumatoid arthritis and an assessment of its influence on hepatic drug-metabolizing enzymes.

× No keyword cloud information.

10 in total

1. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors:
Journal: Ann Rheum Dis Date: 1959-03 Impact factor: 19.103

2. Clinico-pharmacological studies and clinical evaluation of flurbiprofen. A new non-steroidal antirheumatic agent.

Authors: I M Chalmers; B J Cathcart; E B Kumar; W C Dick; W W Buchanan
Journal: Ann Rheum Dis Date: 1972-07 Impact factor: 19.103

3. Pharmacological implications of microsomal enzyme induction.

Authors: A H Conney
Journal: Pharmacol Rev Date: 1967-09 Impact factor: 25.468

4. Effect of flurbiprofen on the metabolism of antipyrine in man.

Authors: I M Chalmers; M A Bell; W W Buchanan
Journal: Ann Rheum Dis Date: 1973-01 Impact factor: 19.103

5. The quantitative measurement of joint changes in rheumatoid arthritis.

Authors: M L Ingpen
Journal: Ann Phys Med Date: 1968-11

6. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors: D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal: Q J Med Date: 1968-07

7. Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

Authors: P L Boardman; F D Hart
Journal: Br Med J Date: 1967-11-04

8. Studies on drug metabolism. IV. Effects of high dose administration of pentobarbital and phenylbutazone on the plasma biologic half lives in various species.

Authors: H Kitagawa; T Kamataki; S Yoshida
Journal: Chem Pharm Bull (Tokyo) Date: 1968-12 Impact factor: 1.645

9. Measurement of joint inflammation. A radioisotopic method.

Authors: W C Dick; R R Neufeld; A G Prentice; A Woodburn; K Whaley; G Nuki; W W Buchanan
Journal: Ann Rheum Dis Date: 1970-03 Impact factor: 19.103

10. Isotope studies in normal and diseased knee joints: 99mTc uptake related to clinical assessment and to synovial perfusion measured by the 133Xe clearance technique.

Authors: W C Dick; S D Deodhar; C J Provan; G Nuki; W W Buchanan
Journal: Clin Sci Date: 1971-04 Impact factor: 6.124

10 in total

7 in total

1. Ketoprofen: a preliminary report of its pharmacological activity and therapeutic efficacy in rheumatic disorders.

Authors: R N Brogden; T M Speight; G S Avery
Journal: Drugs Date: 1974 Impact factor: 9.546

2. Urinary pharmacokinetics of orally administered ketoprofen in man.

Authors: G W Houghton; M J Dennis; E D Rigler; R L Parsons
Journal: Eur J Drug Metab Pharmacokinet Date: 1984 Jul-Sep Impact factor: 2.441

3. Ketoprofen and indomethacin in the treatment of rheumatoid arthritis: a double-blind cross-over trial.

Authors: R Franchi; M Viara; C Liverta; C Pollini; A E Pontiroli
Journal: Eur J Clin Pharmacol Date: 1975-04-04 Impact factor: 2.953

4. Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration.

Authors: T Ishizaki; T Sasaki; T Suganuma; Y Horai; K Chiba; M Watanabe; W Asuke; H Hoshi
Journal: Eur J Clin Pharmacol Date: 1980-11 Impact factor: 2.953

Studies on 2-(3-benzoylphenyl) propionic acid (Orudis). A double-blind cross-over trial in patients with rheumatoid arthritis and an assessment of its influence on hepatic drug-metabolizing enzymes.